Email Us
View Reports

Latin America Active Pharmaceutical Ingredient Market

Latin America Active Pharmaceutical Ingredient Market - By Type (Innovative active pharmaceutical ingredients market, Generic active pharmaceutical ingredients market) By Manufacturing (Captive API Manufacturers, Merchant API Manufacturers) By Synthesis (Synthetic Active Pharmaceutical Ingredients Market, Biotech active pharmaceutical ingredients market) By Therapeutic Application (Oncology, Cardiovascular Diseases, Diabetes, Communicable Diseases, Other) By Region (Brazil, Argentina, Mexico) - Market Size, Share, Trends, Industry Analysis, Growth and Forecast period 2026

  • ID : 93508599  |  
  • Published : May-2019  |  
  • Region : Latin America  |  
  • Pages : 120   |  
  • Publisher : Research Cosmos

Latin America Active Pharmaceutical Ingredient Market Size

The research analyst predicts, the latin America Active Pharmaceutical Ingredient Market Size is estimated to reach a value of USD 32.1 billion, with a CAGR of 5.4 % over the forecasting period 2026

Active pharmaceutical ingredient (API), is the term that is utilized to describe the naturally active part of a medication (for example tablet, container). The API speaks to the essential ingredient. Different ingredients are generally known as "excipients. Some of the time medication can contain a few APIs and its impact on a patient relies upon the measurement endorsed and can fluctuate from individual to individual. In mix therapies, at least two than two active ingredients are utilized to treat various side effects in various ways.

Stringent quality control is a command with regards to the assembling of medications as the API speaks to the primary segment considered while making the remedy. In any case, on account of rapidly extending economies and enhancements in human services, South and Central America (SCA) are set to take a progressively significant piece later on.

Growth Drivers, Restraints, and Opportunities - Latin America Active Pharmaceutical Ingredient Market

Factors, for example, rising geriatric populace which brings forth age-related disease, manufacturing of imaginative medication alongside the ascent popular effective drug with rapid action are driving the development in the Latin American market. Illnesses, for example, malignancy, cardiovascular maladies, hypertension, vision and hearing misfortune, diabetes and a lot more are rapidly found in individuals in the age gathering of 60 or more may lead development in future.

API is always expanding the re-appropriating alongside various techniques for the definition of active medication ingredients because of the termination of the patent of marked medications, therefore, there is no utilization of putting resources into R&D exercises which can profit the organization or the makers. Thusly makers by and large lean toward nonexclusive medications over the marked or perceived ones as a result of the developing deals in the API market.

Others reasons which are using nonexclusive medications incorporate absence of marked medications, exorbitance and poor availability in the remote region of few creating nations. Some administration affiliations are taking measures to direct this issue. The European Union (EU) are setting up gathering workplaces that not simply help in improving the idea of the prescriptions sold in the market yet additionally ensures the ideas of government-supported and quality-checked of consistently made medications.

Nonetheless, there are plans to end that little proportion and redistribute all the assembling get together in the Latin American market. Increment in medicinal services spending is a Latin America wonder, and this straightforwardly profited the generics API market as of late in the creating countries because of extreme interest and simple entry. Be that as it may, the expense of improving procedure plot, greater expense of claim to fame API drugs, and stringent endorsements guidelines may go about as a controlling component to the general advancement of the market.

Geographical Analysis of Latin America Active Pharmaceutical Ingredient Market

Regarding area, the Latin America active pharmaceutical ingredients market has been fragmented into Brazil, Argentina, Mexico, Peru, and others. Mexico ruled the Latin America market and is anticipated to grow at significant share by the end of 2026. The market in this region is essentially determined by a rapid increment in the geriatric populace, high selection of new medications, and ascend in gathering dental practices. The market here is anticipated to extend at a rapid pace amid the gauge time frame.

The SCA area has one of the quickest developing API markets on the planet, with a developing interest for conventional and biologic drugs. On the account of a maturing populace and a reinforcing human services framework, Brazil is expected to overwhelm by 2017.

Prominent Companies in the Latin America Active Pharmaceutical Ingredient Market analyzed in the report are:

  • Lonza Group
  • Boehringer Ingelheim GmbH
  • Teva Pharmaceutical Industries LTD
  • Sanofi
  • Patheon N.V
  • Aurobindo pharmaceuticals.
  • Seigfried Holdings A.G
  • Olon S.p.A
  • Pfizer Inc.
  • GlaxoSmithKline plc.
  • Cambrex Corporation and AMRI.

This research report includes following segmentation for the Latin America Active Pharmaceutical Ingredient Market size and forecast 2026

Latin America Active Pharmaceutical Ingredient Market - By Type

  • Innovative active pharmaceutical ingredients market
  • Generic active pharmaceutical ingredients market

Latin America Active Pharmaceutical Ingredient Market - By Manufacturing

  • Captive API Manufacturers
  • Merchant API Manufacturers

Latin America Active Pharmaceutical Ingredient Market - By Synthesis

  • Synthetic Active Pharmaceutical Ingredients Market
  • Biotech active pharmaceutical ingredients market

Latin America Active Pharmaceutical Ingredient Market - By Type of Drug

  • Prescription Drugs
  • Over the counter Drugs

Latin America Active Pharmaceutical Ingredient Market - By Therapeutic Application

  • Oncology
  • Cardiovascular Diseases
  • Diabetes
  • Communicable Diseases
  • Other

Latin America Active Pharmaceutical Ingredient Market - By Region

  • Brazil
  • Argentina
  • Mexico

  1. Introduction                                                                       
  2. Research Methodology                                                                     

    1. Analysis Design                                               
    2. Research Phases                                                             

      1. Secondary Research                                     
      2. Primary Research                                        
      3. Expert Validation                                         

    3. Study Timeline                                                

  3. Overview                                                                            

    1. Executive Summary                                                        
    2. Key Inferences                                                
    3. New Developments                                                        

  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                              

    1. Latin America Active Pharmaceutical Ingredient Market Drivers                                                
    2. Latin America Active Pharmaceutical Ingredient Market Restraints                                                           
    3. Key Challenges                                                
    4. Current Opportunities in the Latin America Active Pharmaceutical Ingredient Market                                                              

  5. Latin America Active Pharmaceutical Ingredient Market Segmentation

    1. By Product

      1. Innovative active pharmaceutical ingredients market
      2. Generic active pharmaceutical ingredients market
      3. Latin America Active Pharmaceutical Ingredient Market Estimates & Forecasts, by Function, 2026       
      4. Year on Year Growth Rates, by Type, 2026       
      5. Latin America Active Pharmaceutical Ingredient Market Attractiveness Index, by Function, 2026

    2. By Manufacturing

      1. Captive API Manufacturers
      2. Merchant API Manufacturers
      3. Latin America Active Pharmaceutical Ingredient Market Estimates & Forecasts, by Function, 2026       
      4. Year on Year Growth Rates, by Type, 2026       
      5. Latin America Active Pharmaceutical Ingredient Market Attractiveness Index, by Function, 2026 

    3. By Synthesis

      1. Synthetic Active Pharmaceutical Ingredients Market
      2. Biotech active pharmaceutical ingredients market
      3. Latin America Active Pharmaceutical Ingredient Market Estimates & Forecasts, by Function, 2026       
      4. Year on Year Growth Rates, by Type, 2026       
      5. Latin America Active Pharmaceutical Ingredient Market Attractiveness Index, by Function, 2026 

    4. By Type of Drug

      1. Prescription Drugs
      2. Over the counter Drugs
      3. Latin America Active Pharmaceutical Ingredient Market Estimates & Forecasts, by Function, 2026       
      4. Year on Year Growth Rates, by Type, 2026       
      5. Latin America Active Pharmaceutical Ingredient Market Attractiveness Index, by Function, 2026 

    5. By therapeutic Application

      1. Oncology
      2. Cardiovascular Diseases
      3. Diabetes
      4. Communicable Diseases
      5. Other
      6. Latin America Active Pharmaceutical Ingredient Market Estimates & Forecasts, by Function, 2026       
      7. Year on Year Growth Rates, by Type, 2026       
      8. Latin America Active Pharmaceutical Ingredient Market Attractiveness Index, by Function, 2026 

  6. Geographical Analysis

    1. Latin America Active Pharmaceutical Ingredient Market

      1. Introduction
      2. Brazil
      3. Argentina
      4. Mexico

  7. Strategic Analysis                                                              

    1. PESTLE analysis                                                

      1. Political                                        
      2. Economic                                     
      3. Social                                           
      4. Technological                               
      5. Legal                                            
      6. Environmental                                             

    2. Porter’s Five analysis                                                      

      1. Bargaining Power of Suppliers                                    
      2. Bargaining Power of Consumers                                 
      3. Threat of New Entrants                               
      4. Threat of Substitute Products and Services                                
      5. Competitive Rivalry within the Industry            

    3. Supply Chain Analysis

      1. Raw Material Suppliers
      2. Manufacturers/Producers
      3. Distributors/Retailers/Wholesalers/E-Commerce
      4. End Users      

  8. Latin America Active Pharmaceutical Ingredient Market Leaders Analysis                                                                   

    1. Lonza Group

      1. Overview                                      
      2. Product Analysis                                          
      3. Strategic Evaluation and Operations                                            
      4. Financial analysis                                         
      5. Legal issues                                  
      6. Recent Developments                                 
      7. SWOT analysis                                             
      8. Analyst View

    2. Boehringer Ingelheim GmbH
    3. Teva Pharmaceutical Industries LTD
    4. Sanofi
    5. Patheon N.V
    6. Aurobindo pharmaceuticals.
    7. Seigfried Holdings A.G
    8. Olon S.p.A
    9. Pfizer Inc.
    10. GlaxoSmithKline plc.
    11. Cambrex Corporation and AMRI.

  9. Competitive Landscape                                                                     

    1. Latin America Active Pharmaceutical Ingredient Market share analysis                                                    
    2. Merger and Acquisition Analysis                                                    
    3. Agreements, collaborations and Joint Ventures                                                             
    4. New Product Launches                                                   

  10. Expert Opinions                                                               

    1. Latin America Active Pharmaceutical Ingredient Market Outlook                                                              
    2. Investment Opportunities                                                            

  11. Appendix                                                               

    1. List of Tables                                                      
    2. List of Figures                        

Purchase this Market Research Report

REACH OUT TO US

Call us on : +1 888 709 8757

Drop us an email at : info@researchcosmos.com

HAVE A QUESTION?